Boston Scientific Corp.
(NYSE : BSX)

( )
BSX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 3.41%494.361.0%$778.78m
DHRDanaher Corp. 2.22%242.560.7%$647.76m
MDTMedtronic Plc 1.57%125.850.6%$635.61m
ABTAbbott Laboratories 1.98%123.900.8%$617.22m
ALGNAlign Technology, Inc. 1.90%606.236.3%$364.21m
ISRGIntuitive Surgical, Inc. 2.40%804.722.3%$355.09m
NVCRNovoCure Ltd. 6.90%198.836.8%$305.81m
SYKStryker Corp. 1.85%256.961.3%$305.67m
BDXBecton, Dickinson & Co. 3.28%258.021.0%$297.83m
DXCMDexCom, Inc. 2.15%399.497.8%$278.71m
BSXBoston Scientific Corp. 2.98%40.851.0%$257.04m
IDXXIDEXX Laboratories, Inc. 2.78%528.463.7%$233.25m
BAXBaxter International, Inc. 1.36%85.791.8%$227.71m
EWEdwards Lifesciences Corp. 1.98%87.960.4%$222.64m
AAgilent Technologies, Inc. 0.95%133.221.6%$194.87m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.